Absence of deletions but frequent loss of expression of p16(INK4) in human ovarian tumours

British Journal of Cancer

Volumn 76, Issue 2, 1997, Pages 146-149

  Marchini, S ^a   Codegoni, A M ^a   Bonazzi, C ^b   Chiari, S ^b   Broggini, M ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cell cycle protein; Cyclin dependent kinase; Cyclin dependent kinase inhibitor; Ovarian cancer; P16 CDKN2

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; DNA; PROTEIN P16;

ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; OVARY CANCER; OVARY CARCINOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

EID: 0030981136     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.355     Document Type: Article

References (27)

1. Beijersbergen RL and Bernards R (1996) Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim Biophys Acta 1287: 103-120
2. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, Van Der Riet P, Blaugrund JE and Sidransky D (1994) Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265: 415-417
3. Campbell IG, Beynon G, Davis M and Englefield P (1995) LOH and mutation analysis of CDKN2 in primary human ovarian cancer. Int J Cancer 63: 222-225
4. Devlin J, Elder PA, Gabra H. Steel CM and Knowles MA (1996) High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumor-suppressor loci. Br J Cancer 73: 420-423
5. He J, Allen JR, Collins VP, Allalunis Turner MJ, Godhout R, Day RS and James CD (1994) CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 54: 5804-5807
6. Hirama T and Koeffler HP (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86: 841-854
7. Jin XM, Nguyen D, Zhang WW, Kyritsis AP and Roth JA (1995) Cell cycle arrest and inhibition of tumor cell proliferation by the p16 (INK4) gene mediated by an adenovirus vector. Cancer Res 55: 3250-3253
8. Kamb A, Gruis NA, Weaver Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE and Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440
9. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilcyznski S, Lee YY, Bartram CR and Koeffler HP (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kipl in human malignancies. Cancer Res 55: 2266-2269
10. Li R, Hannon GJ, Beach D and Stillman B (1996) Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage. Curr Biol 6: 189-199
11. Maestro R and Boiocchi M (1995) Sunlight and melanoma: an answer from MTS1 (p16). Science 267: 15-16
12. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1: 686-692
13. Nishikawa R, Furnari FB, Lin H, Arap W, Berger MS, Cavenee WK and Huang HJS (1995) Loss of P16(INK4) expression is frequent in high grade gliomas. Cancer Res 55: 1941-1945
14. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756
15. Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain SP, Bennett WP, Forrester K, Gerwin B, Serrano M, Beach DH and Harris CC (1994) Mutations and altered expression of p16INK4 in human cancer. Proc Natl Acad Sci USA 91: 11045-11049
16. Pines J (1995) Cyclins and cyclin-dependent kinases: theme and variations. Adv Cancer Res 66: 181-212
17. Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, Richter KH, Walker C, Beach D, Sherr CJ and Serrano M (1995) Cloning and characterization of murine p16(INK4a) and p15(INK4b) genes. Oncogene 11: 635-645
18. Rodabaugh KJ, Biggs RB, Qureshi JA, Barrett AJ, Welch WR, Bell DA, Berkowitz RS and Mok SC (1995) Detailed deletion mapping of chromosome 9p and p 16 gene alterations in human borderline and invasive epithelial ovarian tumors. Oncogene 11: 1249-1254
19. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY
20. Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilton TC and Godwin AK (1995) Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Cancer Res 55: 2150-2157
21. Sheaff RJ and Roberts JM (1995) Tumor suppression: lessons in p16 from phylum Falconium. Curr Biol 5: 28-31
22. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79: 551-555
23. Sherr CJ and Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163
24. Shiohara M, El Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B and Koeffler HP (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood 84: 3781-3784
25. Spruck CH, Gonzalez Zulueta M, Shibala A, Simoneau AR, Lin MF, Gonzales F, Tsai YC and Jones PA (1994) p16 gene in uncultured tumours. Nature 370: 183-184
26. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G and Kamb A (1995) Complex structure and regulation of the P16 (MTS1) locus. Cancer Res 55: 2988-2994
27. Zhang SY, Klein Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA and Goodrow TL (1994) Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 54: 5050-5053